Can Men Take Myo-Inositol? Benefits and Safety

Men can take myo-inositol, and a growing body of research suggests they stand to benefit from it in several ways. Although myo-inositol supplements are marketed overwhelmingly toward women with polycystic ovary syndrome (PCOS), the molecule itself is not sex-specific. It is a naturally occurring sugar alcohol that your body already produces and that you consume in food every day. The research in men, while smaller than the PCOS literature, spans fertility, hormonal balance, metabolic health, and even mental health, and the safety profile is consistently favorable.

What Myo-Inositol Actually Does in the Body

Myo-inositol is one of nine forms (isomers) of inositol, and it is the most abundant one in human tissue. Your body synthesizes it from glucose, and you also get it from foods like citrus fruits, beans, grains, and nuts. Dietary intake from food alone ranges from roughly 225 to 1,500 mg per day depending on what you eat.¹ At the cellular level, myo-inositol and its sibling D-chiro-inositol participate in insulin signaling and glucose metabolism through several distinct pathways.² It also serves as a building block for cell membranes and plays a role in how cells communicate through chemical messengers. These functions are not limited to female physiology, which is why the compound has relevant effects in men.

Sperm Quality and Male Fertility

The most studied benefit of myo-inositol in men is its effect on sperm. Myo-inositol is found at high concentrations in seminal fluid naturally, and supplementing with it appears to improve sperm motility, which is the ability of sperm to swim effectively. A 2024 systematic review and meta-analysis pooling data from multiple trials found that myo-inositol treatment was associated with a meaningful increase in both total sperm motility and progressive sperm motility, along with improved testosterone levels.³ An earlier review in the journal Andrology also reported improvements in sperm motility in both fresh and frozen-thawed semen, with better sperm performance in both natural and assisted fertility settings.⁴

A randomized clinical trial in men with low sperm count and poor motility who were undergoing intrauterine insemination (IUI) found that myo-inositol significantly increased sperm motility during treatment, with improvements visible at multiple stages of sperm preparation.⁵ The consistency of these findings across different study designs is encouraging, though the total number of men studied remains modest compared to, say, large cardiovascular trials.

How It Works at the Sperm Level

The mechanism behind myo-inositol’s effect on sperm involves mitochondrial function and protection against oxidative damage. Sperm cells are highly metabolically active and rely on their mitochondria for the energy (ATP) needed to swim. Lab studies show that when sperm are incubated with myo-inositol, there is a significant increase in oxygen consumption, the main indicator of how efficiently mitochondria are producing energy, in both resting and capacitated samples. Myo-inositol also protects sperm DNA from oxidative damage, which is relevant because DNA fragmentation in sperm is linked to lower fertility and higher miscarriage risk.⁶

These effects have practical applications in fertility clinics. When myo-inositol is added directly to semen samples during in vitro fertilization (IVF) preparation, it improves progressive motility in men with normal sperm as well as in men with poor sperm parameters.⁷ Research also suggests that myo-inositol acts both directly on sperm cells and on the earlier process of sperm production (spermatogenesis), improving performance when given orally and when applied directly to ejaculated sperm.⁸

Effects on Testosterone and Reproductive Hormones

Beyond sperm quality, myo-inositol influences the hormonal environment in men. A study in men with metabolic syndrome found that myo-inositol supplementation with antioxidants led to significant increases in both free and total testosterone levels. Estradiol and sex-hormone-binding globulin (SHBG) decreased, while luteinizing hormone (LH) went up. FSH was the only hormone that stayed unchanged.⁹ Rising testosterone alongside falling estradiol is a hormone shift most men would consider favorable, and it aligns with what you would expect from improved insulin signaling, since insulin resistance tends to push the testosterone-to-estrogen ratio in the wrong direction.

A separate double-blind, placebo-controlled trial in men with idiopathic infertility found that myo-inositol rebalanced LH, FSH, and inhibin B concentrations, suggesting it helps normalize the signaling loop between the brain and the testes rather than simply forcing one hormone higher.¹⁰ This is a meaningful distinction: the evidence so far points to regulatory normalization, not pharmacological boosting. Men with already-normal hormone levels should not expect myo-inositol to push testosterone beyond its natural range.

Metabolic Health and Lipid Profiles

Since myo-inositol is involved in insulin signaling, researchers have tested whether it helps with metabolic problems like high blood sugar, insulin resistance, and poor cholesterol profiles. A systematic review and meta-analysis of randomized controlled trials found that inositol supplementation in people with metabolic diseases significantly lowered triglycerides, total cholesterol, and LDL cholesterol. It did not significantly change HDL cholesterol.¹¹ Most of the participants in those trials were women with PCOS, so some caution is warranted in directly applying the numbers to men. But the metabolic pathways that inositol acts on are not sex-specific, and the direction of the effect is consistent with what individual male-focused studies have reported.

A trial in obese patients with non-alcoholic fatty liver disease found that myo-inositol supplementation improved several cholesterol-related atherogenic indices within the supplementation group, though the changes did not reach statistical significance when compared to the control group.¹² The takeaway is that myo-inositol is not a substitute for statins or lifestyle changes if you have seriously elevated cholesterol, but it may contribute modestly when metabolic dysfunction is part of the picture.

Thyroid Function

An area of research that is often overlooked in the male context is thyroid health. Men develop autoimmune thyroiditis and subclinical hypothyroidism too, even though these conditions are more common in women. A study of patients with autoimmune thyroiditis found that myo-inositol combined with selenium significantly reduced TSH levels, from an average of 4.32 to 3.12, pushing borderline-high readings back toward the normal range.¹³ A later meta-analysis confirmed a significant decrease in TSH with combined myo-inositol and selenium supplementation.¹⁴

The selenium component matters here. Most of the thyroid studies used both supplements together, so it is not clear how much myo-inositol alone would accomplish for thyroid markers. If you are a man with borderline thyroid function and are considering myo-inositol partly for this reason, the evidence suggests the combination is what works. Taking myo-inositol alone for thyroid support has less backing.

Erectile Dysfunction

A double-blind, randomized, placebo-controlled study tested a myo-inositol and folic acid combination in men with type 2 diabetes who had erectile dysfunction. The researchers concluded that the combination deserves consideration as a treatment option, likely because of its metabolic effects (improving insulin sensitivity) alongside its antioxidant properties, including protection of nitric oxide, which is the key molecule involved in achieving erections.¹⁵ An ex vivo study exploring myo-inositol’s antioxidant and anticoagulant properties suggested it should be further investigated for vascular dysfunction scenarios, including erectile dysfunction and prostate enlargement.¹⁶

The erectile dysfunction evidence is thin compared to the fertility data. One well-designed trial and some supporting lab work are promising but not enough to call myo-inositol a proven treatment for ED. If your erectile dysfunction is connected to diabetes or metabolic syndrome, myo-inositol’s broader metabolic benefits could plausibly help, but it is not a replacement for established options like PDE5 inhibitors.

Mental Health Applications

Myo-inositol has been investigated in psychiatric contexts because it is a precursor to the phosphatidylinositol second-messenger system, which is involved in how serotonin and other neurotransmitters work in the brain. Some early studies found it was effective for panic disorder, depression, and obsessive-compulsive disorder (OCD).¹⁷ One small crossover trial directly compared myo-inositol (at doses up to 18 grams per day) against fluvoxamine for panic disorder and found that myo-inositol reduced panic attacks more than the drug, with similar improvements on anxiety and global impression scales.¹⁸

However, the larger picture is less clear. A Cochrane systematic review of inositol for depression identified only four small, short-term trials totaling 141 participants and found no clear evidence of therapeutic benefit.¹⁹ A more recent narrative review concluded that while imaging and molecular studies point to a role for inositol in mood disorder biology, the clinical trial data for both mood and psychotic disorders remain controversial and inconsistent.²⁰ The mental health doses studied (12 to 18 grams per day) are also far higher than what most people take for metabolic or fertility purposes, which complicates the practical picture. If you are considering myo-inositol primarily for anxiety or depression, the evidence is intriguing but far from settled, and those doses carry more risk of gastrointestinal side effects.

Skin Conditions and Acne

Myo-inositol’s influence on androgen levels makes it relevant to skin conditions driven by hormonal imbalance. A prospective study that included both male and female participants tested a myo-inositol-based herbal supplement for non-cystic acne. After eight weeks, inflammatory lesions decreased by about 61% and non-inflammatory lesions by about 62% in the myo-inositol group. The supplement also lowered 17-OHP and androstenedione, two androgens implicated in acne. Men made up about 22% of the supplement group, and the researchers noted that myo-inositol at similar or higher doses has been previously studied in men for fertility and erectile dysfunction, supporting its safety in male individuals.²¹

In a different dermatological context, myo-inositol combined with folic acid and liposomal magnesium was tested as an add-on to antibiotics in patients with hidradenitis suppurativa, a painful chronic skin condition. The group receiving the supplement showed a significantly greater reduction in disease severity scores after six months, along with a meaningful drop in insulin resistance as measured by HOMA-IR.²² These are niche applications, but they illustrate that myo-inositol’s effects in men extend beyond the reproductive system whenever insulin resistance or androgen imbalance is part of the problem.

Myo-Inositol Versus D-Chiro-Inositol

If you have looked into inositol supplements, you have probably encountered D-chiro-inositol (DCI) as well, sometimes sold alongside myo-inositol in a 40:1 ratio that mirrors their proportions in the body. In the female PCOS literature, combining the two is common. In men, the picture is slightly different. A pilot study in older men with low-normal testosterone found that DCI alone (1,200 mg per day for 30 days) increased androgen levels, reduced estrogen, improved blood sugar markers, and was associated with reduced weight, BMI, and waist circumference. No adverse events were reported.²³

Meanwhile, a lab study found that DCI improved sperm mitochondrial membrane potential in a dose-dependent manner in both normal and poor-motility sperm samples. The proportion of sperm with high mitochondrial energy status increased significantly after DCI incubation. That said, the fertility literature overall has focused more heavily on myo-inositol for sperm quality, and the meta-analyses discussed earlier used myo-inositol rather than DCI. For men interested primarily in fertility support, myo-inositol has the stronger evidence base. For men focused on testosterone and metabolic markers, DCI or a combination may be worth considering, though the evidence is still at the pilot-study stage.

Dosage Ranges Used in Male Studies

There is no single official dose recommendation for men, because myo-inositol is classified as a supplement rather than a drug. The doses used across the male-focused studies vary by the condition being targeted. For fertility and hormonal support, most trials used between 2 and 4 grams of myo-inositol per day, often combined with 400 micrograms of folic acid. The metabolic syndrome study that showed testosterone increases used myo-inositol alongside antioxidants. The mental health studies used dramatically higher doses, ranging from 12 to 18 grams per day, which are not typical for the average user.

Your body already makes some myo-inositol on its own and you get more from food, so supplementation adds to an existing baseline. The most commonly reported side effect at standard doses (2 to 4 grams) is mild gastrointestinal discomfort: bloating, gas, or loose stools. At the high psychiatric doses, these effects become more likely and more pronounced. Across the studies reviewed here, serious adverse events were not reported in any of the male-focused trials, and the compound is generally regarded as well tolerated. If you are on medications, particularly those that affect insulin sensitivity, lithium, or psychiatric medications, talking to your doctor before adding myo-inositol is still a reasonable precaution.

Why the Marketing Skews Female

The reason myo-inositol is so strongly associated with women’s health comes down to research history. The biggest driver of clinical trials was PCOS, a condition that affects roughly one in ten women and involves insulin resistance, androgen excess, and ovulatory dysfunction. Myo-inositol turned out to help on all three fronts in that population, which created commercial demand. Supplement companies followed the market, branding their products with language aimed at women trying to conceive or managing PCOS symptoms. The result is a perception gap: the molecule does not care about your sex, but the packaging does.

Men researching myo-inositol often run into this wall of pink branding and fertility-clinic language, which can make the product feel irrelevant to them. The science tells a different story. The metabolic and insulin-sensitizing effects are mechanism-driven, not hormone-driven, and they apply to anyone whose cells use insulin (which is everyone). The fertility effects in men are just as well-documented as many of the vitamin and antioxidant blends marketed for male reproductive health, and arguably better supported by controlled trials than some popular alternatives. The gap is in marketing, not in biology.